News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Earnings
Auris Medical AG (EARS) Reports Second Quarter 2014 Financial Results and Provides Business Update 9/15/2014
Loxo Oncology (LOXO) Announces Second Quarter 2014 Financial Results 9/12/2014
Parnell Pharmaceuticals Holdings To Report Fiscal Year 2014 Financial Results September 15, 2014 9/11/2014
Avalanche Biotechnologies (AAVL) Reports Second Quarter 2014 Financial Results 9/11/2014
Misonix Incorporated (MSON) Announces Fourth Quarter and Fiscal Year End 2014 Financial Results 9/11/2014
Centene Corporation Schedules 2014 Third Quarter Financial Results Conference Call 9/11/2014
Verona Pharma (VRP.L) Release: Interim Results For The Six Months Ended 30 June 2014 9/11/2014
PDL BioPharma, Inc. (PDLI) Provides Third Quarter 2014 Revenue Guidance Of $165 Million 9/10/2014
Unilife Corporation (UNIS) Announces Financial Results For The Fourth Quarter And Full Fiscal Year 2014 9/10/2014
Peregrine Pharmaceuticals, Inc. (PPHM) Reports First Quarter Fiscal Year 2015 Financial Results And Recent Developments 9/10/2014
Leidos Holdings, Inc. Reports Second Quarter Fiscal Year 2015 Results 9/9/2014
Palatin Technologies (PTN) Reports Fourth Quarter And Fiscal Year End 2014 Results 9/9/2014
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) Reports Fiscal Year 2014 Results 9/9/2014
Champions Oncology, Inc. (CSBR) To Announce First Quarter Financial Results On Thursday, September 11 9/9/2014
TRANSGENE (ENX:TNG) Reports Financial Results For First Six Months Of 2014 And Provides Update On TG4010 9/9/2014
Loxo Oncology (LOXO) To Announce Second Quarter 2014 Financial Results 9/5/2014
Palatin Technologies (PTN) To Report Fourth Quarter And Fiscal Year 2014 Results 9/5/2014
Catalent Reports Fourth Quarter and Fiscal Year 2014 Results 9/5/2014
Simulations Plus (SLP) Reports Preliminary Revenues For Fourth Fiscal Quarter FY2014 9/4/2014
pSivida Corp (PSDV) Announces Fourth Quarter And Fiscal Year 2014 Financial Results Release Date And Conference Call Information 9/4/2014
Biomerica (BMRA) Announces Year End Results 9/4/2014
Scancell Release: Final Results For The Year Ended 30 April 2014 9/4/2014
XTL Biopharmaceuticals Ltd. (XTLB) Provides Financial And Operational Update For The Second Quarter of 2014 9/3/2014
Peregrine Pharmaceuticals, Inc. (PPHM) To Report First Quarter Fiscal Year 2015 Financial Results After Market Close On September 9, 2014 9/3/2014
Can-Fite BioPharma (CFBI) Reports First Six Months 2014 Results 9/3/2014
uniQure Announces Results For The Second Quarter And First Half Of 2014 And Provides Update On Gene Therapy Programs 9/2/2014
ERYtech Pharma Business Update And Financial Results For The First Half Of 2014 9/2/2014
Pfenex Inc. (PFNX) Reports Second Quarter 2014 Results And Provides Business Update 9/2/2014
BioBlast Pharma (ORPN) Reports Second Quarter Financial Results 8/29/2014
Agile Therapeutics, Inc. To Ring The NASDAQ Stock Market Closing Bell 8/29/2014
Immucor To Host Debt Investor Conference Call On Thursday, September 4, 2014 8/29/2014
China Cord Blood Corporation Reports First Quarter Fiscal 2015 Financial Results 8/29/2014
DelMar Pharmaceuticals Fiscal 2014 Year End Results And Summary Of Recent Developments 8/29/2014
iCo Therapeutics Inc. Announces Second Quarter 2014 Financial Results 8/29/2014
Ipsen (IPN.PA): 2014 Half-Year Results And 2014 Objectives 8/29/2014
Ocular Therapeutix, Inc. (OCUL) Announces Second Quarter 2014 Financial Results 8/29/2014
Radient Technologies Inc. Releases First Quarter Results 8/29/2014
Ablynx (ABLYF) Announces Half-Year Results For 2014 8/28/2014
Bavarian Nordic (BAVA.CO) Announces First Half 2014 Results 8/28/2014
Allied Minds Half-Yearly Report 2014 8/28/2014
Oxford BioMedica PLC (OXB.L) Interim Results For The Six Months Ended 30 June 2014 8/28/2014
Antibe Therapeutics Inc. Reports Q1 2015 Interim Financial And Operating Results 8/28/2014
Cyprotex (COTXF.PK) Interim Results 2014 8/28/2014
QRxPharma Ltd. (QRXPY): ASX Preliminary Final Report – 2014 Financial Year 8/28/2014
Pivotal Therapeutics Inc. Announces Second Quarter Financial Results 8/28/2014
With Revenues From Diabetes And Cardiovascular Portfolio At Risk, Analysts Remain Cautious About Sanofi India 8/27/2014
Macrocure (MCUR) Announces Second Quarter 2014 Financial Results 8/27/2014
Amarantus BioSciences, Inc. Reports Second Quarter 2014 Financial Results, Announces Business Update Call 8/27/2014
BioReference Laboratories, Inc. (BRLI) Reports Record Quarterly Revenues And Patient Volumes For Third Quarter FY2014 8/27/2014
Kewaunee Scientific Corporation Increases Quarterly Dividend 8/27/2014
Immunomedics, Inc. (IMMU) Announces Fiscal 2014 Results And Clinical Program Developments 8/26/2014
TiGenix Business And Financial Update For The First Half Of 2014 8/26/2014
Nordic Nanovector: Second Quarter Report 2014 8/26/2014
PhotoCure: Results For Second Quarter And The First Half Year 2014 8/26/2014
Aceto Corporation Schedules Fourth Quarter & Fiscal 2014 Financial Results News Release and Conference Call 8/22/2014
Cardio3 BioSciences Reports 2014 Half Year Financial Results And Business Update 8/22/2014
Cellectar Biosciences  (NVLT) Reports Second Quarter 2014 Financial Results And Recent Highlights 8/21/2014
Ablynx (ABLYF) Will Announce Its Half-Year Results For 2014 With Webcast 8/21/2014
China Cord Blood Corporation To Report First Quarter Of Fiscal 2015 Financial Results 8/21/2014
Medivir AB (MVRBF): Interim Report, January – June 2014* 8/21/2014
DiaGenic ASA: Q2 2014 - Financial Report 8/21/2014
Karolinska Development AB (publ) – Interim Report January – June 2014 8/21/2014
MDxHealth, Inc. (MXDHF) Reports First Half Year 2014 Results 8/21/2014
Skyepharma PLC (SKYEF) Interim Results Statement 8/21/2014
TiGenix: Convening Notice To The Extraordinary Shareholders' Meeting To Be Held On 8 September 2014 8/21/2014
BioReference Laboratories, Inc. (BRLI) Announces Earnings Date For Third Quarter Fiscal Year 2014 8/20/2014
NeuroVive Pharmaceutical AB: Interim Report 1 Jan. 2014 To 30 Jun. 2014 8/20/2014
Hikma Pharmaceuticals Delivers Excellent First Half Results With 16% Revenue Growth And 44% Increase In Adjusted EPS 8/20/2014
Source BioScience Release: Half Year Report For The Six Months Ended 30 June 2014 8/20/2014
Cellectar Biosciences  (NVLT) To Host Conference Call On August 20th To Discuss Second Quarter 2014 Results And Provide Quarterly Update On Development Progress 8/19/2014
PDL BioPharma, Inc. (PDLI) Announces Second Quarter 2014 And Year To Date Financial Results 8/19/2014
Probi: Highest-Ever Net Sales For A Single Quarter 8/19/2014
Notice Of Zealand Pharma  (ZEAL.CO)'s Interim Report For H1 2014 And Related Conference Call 8/18/2014
Bio-Path Holdings, Inc. (BPTH) Reports Second Quarter 2014 Operational and Financial Results 8/18/2014
PDL BioPharma, Inc. (PDLI) Announces Plans To Issue Second Quarter Financial Results After Market Today And Reschedules Earnings Call For Tuesday, August 19 At 4:30pm EDT 8/18/2014
GlobeImmune, Inc. (GBIM) Announces Second Quarter 2014 Financial Results 8/18/2014
Aeolus Pharmaceuticals Inc. (AOLS.OB) Announces Third Quarter Fiscal Year 2014 Financial Results And Achievements In Lung-ARS Development Program 8/18/2014
Elite Pharmaceuticals, Inc. (ELI) Reports Financial Results For The First Quarter Of Fiscal Year 2015 8/15/2014
ZS Pharma (ZSPH) Announces Second Quarter 2014 Financial Results 8/15/2014
Aurinia (ISA.TO) Reports Second Quarter 2014 Financial Results 8/15/2014
Arno Therapeutics Reports Second Quarter 2014 Financial And Business Update 8/15/2014
Kite Pharma, Inc. Reports Second Quarter 2014 Results 8/15/2014
Opexa Therapeutics (OPXA) Reports Second Quarter 2014 Financial Results And Provides Corporate Update 8/15/2014
RestorGenex Reports Second Quarter 2014 Financial Results 8/15/2014
Agilent Technologies Inc. (A) Reports Third-Quarter 2014 Results 8/15/2014
La Jolla Pharmaceutical Company (LJPC) Announces Second Quarter And Year-To-Date 2014 Financial Results 8/15/2014
Targeted Medical Pharma Reports Second Quarter 2014 Financial Results 8/15/2014
Sinovac Biotech Ltd. (SVA) Reports Unaudited Second Quarter Financial Results 8/15/2014
Yew Bio-Pharm Group Reports 2014 Second Quarter Financial Results 8/15/2014
Ruthigen Reports Fiscal First Quarter 2015 Financial Results 8/15/2014
Intrexon Corporation Announces Second Quarter And First Half 2014 Financial Results 8/15/2014
Dyadic International, Inc. Reports Q2 2014 Financial Results 8/15/2014
Nephros Inc. (NEP) Reports Second Quarter 2014 Financial Results 8/15/2014
Echo Therapeutics (ECTE) Announces Second Quarter 2014 Financial Results and Provides Business Update 8/14/2014
Heat Biologics Reports 2014 Second Quarter Financial Results 8/14/2014
Stemline Therapeutics, Inc. (STML) Provides Second Quarter 2014 Financial Results And Corporate Update 8/14/2014
Aastrom Biosciences, Inc. (ASTM) Reports Second Quarter 2014 Financial Results 8/14/2014
Emisphere Technologies, Inc. (EMIS) Announces Financial Results For Quarter Ended June 30, 2014 8/14/2014
Catalyst Pharmaceutical Partners, Inc. (CPRX) Announces Second Quarter 2014 Financial Results 8/14/2014
Capstone Therapeutics (CAPS) Will Provide An Operating Update And Announces Second Quarter 2014 Financial Results 8/14/2014
Cellular Biomedicine Group (CBMG) Reports Second Quarter And First Half 2014 Financial Results And Provides Business Highlights 8/14/2014
Perrigo Company (PRGO) Announces Quarterly Dividend 8/14/2014
Interleukin Genetics Inc. (ILGN) Reports Second Quarter 2014 Financial Results 8/14/2014
Kindred Bio (KIN) Announces Second Quarter 2014 Financial Results 8/14/2014
SAGE Therapeutics Reports Second Quarter 2014 Financial Results 8/14/2014
Kamada Ltd. (KMDA) Reports Second Quarter Financial Results 8/14/2014
22nd Century Group, Inc. Reports Second Quarter 2014 Financial Results 8/14/2014
Veracyte, Inc. (VCYT) Announces Second Quarter 2014 Financial Results 8/14/2014
Rexahn Pharmaceuticals, Inc. (RNN) Reports Second Quarter 2014 Financial Results And Pipeline Update 8/14/2014
BASi (BASI) Reports Third Quarter Net Income Of $.03 Per Share 8/14/2014
PDI, Inc. (PDII) Reports 2014 Second Quarter Financial Results 8/14/2014
WuXi PharmaTech Co., Ltd. Announces Second-Quarter 2014 Results 8/14/2014
Imprimis Pharmaceuticals (immy) Announces Second Quarter 2014 Financial Results And Provides Operational Update 8/14/2014
Biotage AB (BIOTa.ST): Interim Report For The Period January – June 2014 8/14/2014
Recipharm AB: Interim Report January-June 2014 8/14/2014
InSite Vision (ISV) Reports Second Quarter 2014 Financial Results 8/14/2014
Concordia Healthcare Corp (CXR.TO) Announces Financial And Operational Results For Its Second Quarter, Ended June 30, 2014 8/14/2014
DATATRAK International, Inc. (DATA) Reports Second Quarter Results Of 2014 8/14/2014
Concord Medical Services Holdings Limited (CCM) Reports Second Quarter 2014 Financial Results 8/14/2014
Synthetic Biologics, Inc. (SYN) Reports Second Quarter 2014 Financial Results And Operational Highlights 8/14/2014
CASI Pharmaceuticals  (ENMD) Reports Second Quarter 2014 Financial Results 8/14/2014
RXi Pharmaceuticals (RXII) Reports Financial Results For The Second Quarter Of 2014 8/14/2014
Perrigo Company (PRGO) Reports Record Fourth Quarter And Fiscal Year Revenue, Adjusted Operating Income And Adjusted Margins 8/14/2014
Biostar Pharmaceuticals, Inc. (BSPM) Announces Second Quarter 2014 Financial Results 8/14/2014
VWR International, Inc. To Hold Second Quarter 2014 Financial Results Conference Call 8/14/2014
Cord Blood America, Inc. Announces 2014 Second Quarter Financial Results 8/14/2014
RBC Life Sciences, Inc. Reports Second Quarter Results 8/14/2014
HEALTHSOUTH To Present At The Baird 2014 Healthcare Conference 8/14/2014
Pressure BioSciences, Inc. (BBII) Reports Second Quarter 2014 Financial Results And Provides Business Update 8/14/2014
Inergetics, Inc.: 2014 Second Quarter Earnings Announcement 8/14/2014
Microbix Biosystems Inc. (MBXBF)’ Virology Revenue Grows 24% In Third Quarter, Company Reports Fourth Consecutive Quarterly Profit 8/14/2014
SYGNIS Pharma AG Reports Half-Year Results For The Period Ended June 30, 2014 8/14/2014
Elite Pharmaceuticals, Inc. (ELI) To Host Quarterly Business Update Call On August 18, 2014 8/13/2014
Anavex Life Sciences Corp. (AVXL.OB) Reports Fiscal Third Quarter 2014 Financial Results 8/13/2014
SCYNEXIS, Inc. (SCYX) Reports Second Quarter 2014 Financial Results 8/13/2014
Epizyme (EPZM) Announces Second Quarter 2014 Financial Results And Provides Corporate Update 8/13/2014
Eleven Biotherapeutics (EBIO) Reports Second Quarter 2014 Financial Results 8/13/2014
TetraPhase Pharmaceuticals Reports Second-Quarter 2014 Financial Results 8/13/2014
bluebird bio (BLUE) Reports Fiscal Second Quarter 2014 Financial Results 8/13/2014
Arrowhead Research Corporation (ARWR) Reports Fiscal 2014 Third Quarter Financial Results And Provides Update On ARC-520 8/13/2014
Ignyta (RXDX) Announces Second Quarter 2014 Company Highlights And Financial Results 8/13/2014
Moberg Pharma AB (Formerly known as Moberg Derma) Interim Report January - June 2014 8/13/2014
Ambit Biosciences Announces Second Quarter 2014 Operating Results 8/13/2014
Pressure BioSciences, Inc. (BBII) To Discuss Second Quarter 2014 Financial Results And Provide A Business Update 8/13/2014
Capricor Therapeutics, Inc. Reports Second Quarter 2014 Financial & Business Highlights 8/13/2014
Tengion Inc. Provides Clinical Update And Reports Second Quarter 2014 Financial Results 8/13/2014
Emisphere Technologies, Inc. (EMIS) Announces Second Quarter 2014 Earnings Conference Call 8/13/2014
Kindred Bio (KIN) Announces Second Quarter 2014 Financial Results 8/13/2014
Lipocine Inc. (LPCN) Announces Financial And Operational Results For The Second Quarter Of 2014 8/13/2014
Conatus Pharmaceuticals Inc. Reports Second Quarter 2014 Financial Results And Program Updates 8/13/2014
Onconova Therapeutics Inc. (ONTX) Reports Second Quarter 2014 Financial And Operational Results 8/13/2014
Evoke Pharma, Inc. Reports Second Quarter 2014 Results 8/13/2014
Argos Therapeutics, Inc. (ARGS) Reports Second Quarter 2014 Financial Results And Operational Highlights 8/13/2014
Zafgen (ZFGN) Reports Second Quarter 2014 Financial Results 8/13/2014
Tekmira Pharmaceuticals Corporation (TKMR) Provides Corporate Update And Announces Second Quarter 2014 Results 8/13/2014
Epigenomics AG Announces H1 2014 And Q2 2014 Financial Results And Reports On Operational Highlights 8/12/2014
Dipexium Pharmaceuticals (DPRX) Reports Second Quarter 2014 Financial and Operational Results 8/12/2014
CytoSorbents, Inc. Records Another Solid Quarter Of Growth In Q2 2014 8/12/2014
Fate Therapeutics (FATE) Reports Second Quarter 2014 Financial Results 8/12/2014
StemCells Inc. (STEM) Reports Second Quarter 2014 Financial Results And Provides Business Update 8/12/2014
Amphastar Pharmaceuticals, Inc. (AMPH) Reports Revenues Of $49.0 Million For The Second Quarter Ended June 30, 2014 8/12/2014
Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Second Quarter 2014 Financial Results 8/12/2014
ReVance Therapeutics, Inc. (RVNC) Releases Second Quarter 2014 Financial Results 8/12/2014
Cerulean Pharma Inc. (CERU) Reports Second Quarter 2014 Corporate Highlights And Financial Results 8/12/2014
Corium International, Inc. Reports Third Fiscal Quarter 2014 Financial Results 8/12/2014
Ocera Therapeutics, Inc. (OCRX) Reports Second Quarter 2014 Financial Results 8/12/2014
Relypsa, Inc. (RLYP) Announces Second Quarter 2014 Financial Results 8/12/2014
Intercept Pharmaceuticals (ICPT) Reports Second Quarter 2014 Financial Results And Provides Business Update 8/12/2014
Achaogen (AKAO) Announces Second Quarter 2014 Results 8/12/2014
Aquinox Pharmaceuticals (AQXP) Announces Second Quarter 2014 Financial Results 8/12/2014
Galena Biopharma  (GALE) Reports Second Quarter 2014 Results 8/12/2014
Supernus Pharmaceuticals (SUPN) Announces Second Quarter 2014 Results 8/12/2014
Cellular Dynamics International International Reports Second Quarter 2014 Financial Results 8/12/2014
Athersys, Inc. (ATHX) Reports Second Quarter 2014 Results 8/12/2014
Apricus Biosciences (APRI) Provides Corporate Update And Second Quarter 2014 Financial Results 8/12/2014
Evotec AG (EVTG.F) Reports Results Of First Half Of 2014 8/12/2014
Recro Pharma (REPH) Reports Second Quarter 2014 Financial Results 8/12/2014
Akers Biosciences, Inc. Reports Its Second Quarter Financial Results 8/12/2014
ProSensa Holding N.V. (RNA) Announces 2nd Quarter 2014 Financial Results And Recent Corporate Developments 8/12/2014
Intra-Cellular Therapies, Inc. Reports Financial Results For Second Quarter Ended June 30, 2014 8/12/2014
Receptos (RCPT) Reports Second Quarter 2014 Financial Results 8/12/2014
Radius (RDUS) Reports Second Quarter 2014 Financial And Operating Results 8/12/2014
Aurinia (ISA.TO) To Present At The Canaccord Genuity 34th Annual Growth Conference 8/12/2014
Synergy Pharmaceuticals Reports Second Quarter And First Half 2014 Financial Results 8/12/2014
Opko Health, Inc. Announces Second Quarter Operating And Financial Results 8/12/2014
AcelRx Pharmaceuticals (ACRX) Reports Second Quarter 2014 Financial Results 8/12/2014
ADMA Biologics, Inc. Reports Second Quarter 2014 Financial And Operational Results 8/12/2014
NephroGenex (NRX) Reports Second Quarter 2014 Financial Results 8/12/2014
BioSpecifics Technologies Corporation (BSTC) Reports Second Quarter 2014 Financial Results 8/12/2014
AVEO Oncology (AVEO) Reports Second Quarter 2014 Financial Results And Updates Progress On Strategic Plan 8/12/2014
Puma Biotechnology (PBYI) Reports Second Quarter 2014 Financial Results 8/12/2014
Omeros Corporation (OMER) Reports Second Quarter 2014 Financial Results 8/12/2014
Cytori Therapeutics, Inc. (CYTX) Reports Second Quarter 2014 Business And Financial Results 8/12/2014
Oncothyreon Inc. (ONTY) Reports Second Quarter 2014 Financial Results 8/12/2014
Acceleron Pharma Reports Second Quarter 2014 Financial Results 8/12/2014
Retrophin, Inc. (RTRX) Reports Second Quarter 2014 Financial Results 8/12/2014
Halozyme Therapeutics, Inc. (HALO) Reports Second Quarter 2014 Financial Results 8/12/2014
Taxus Cardium (CRXM) Presents Second Quarter 2014 Financial Results And Recent Developments 8/12/2014
Rock Creek Pharmaceuticals Reports Second Quarter And Announces Clinical Update 8/12/2014
BioTime (BTX) Announces Second Quarter 2014 Results And Recent Developments 8/12/2014



//-->